RB Global
RB Global's revenue rose 7.2% to $4.6 billion in fiscal 2025. Its operating margin was 15.5%, down from 17.8% a year earlier. Free cash flow was $719 million, down 5.9%. It paid out $258 million in dividends and buybacks, 36% of free cash flow. The diluted share count rose 0.9%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 10.2% a year and net income 18.7% a year, as new shares raised the share count by 74% and diluted each share's earnings.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value RB Global yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from RB Global's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from RB Global's fiscal 2025 free cash flow of $719M, net cash of −$2.0B at December 31, 2025 and 187 million diluted shares, from its filings. The scenarios are fitted to RB Global: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 38.3% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 9% for a business of moderate risk (Diversified Support Services); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $84.69
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from RB Global's earnings per share of $2.32 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 26.7×, the middle of RB Global's own P/E today, its peers' median and its sector's median (the Industrials median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 10%, 9% and 8%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $84.69
- Value at this multiple, against the last close
- —
- RB Global's P/E at the last close
- 36.5×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| RB GlobalRBA | $84.69 | $2.32 | 36.5× |
| CoreCivicCXW | $29.87 | $1.24 | 24.1× |
| CopartCPRT | $29.15 | $1.55 | 18.8× |
| Science Applications IntlSAIC | $148.51 | $8.56 | 17.3× |
| KBRKBR | $40.02 | $3.33 | 12.0× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 326 | 494 | 576 | 534 | 532 |
| Debt incl. finance leases | 1,766 | 635 | 3,115 | 2,704 | 2,573 |
| Net debt (negative means net cash) | 1,440 | 141 | 2,539 | 2,171 | 2,042 |
| Net debt to EBITDA | 4.4x | 0.3x | 3.1x | 1.8x | 1.7x |
| Debt to equity | 1.6x | 0.5x | 0.6x | 0.5x | 0.5x |
| Interest coverage | 6.5x | 7.8x | 2.2x | 3.3x | 3.7x |
| Current ratio | 1.3x | 1.2x | 1.4x | 1.3x | 1.1x |
| Quick ratio | 1.1x | 1.1x | 1.2x | 1.2x | 1.0x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 2 insiders bought $325,537 of RB Global shares on the open market, and 2 insiders sold $2.4 million, all of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Deborah SteinDirector | Bought | 500 | $80.91 | $40,454 | Form 4 |
| Aug 24, 2026 | Chloe HarfordDirector | Bought | 1,200 | $83.74 | $100,488 | Form 4 |
| Jun 25, 2026 | Christopher CarlsonChief Accounting Officer | Sold plan | 150 | $115.00 | $17,250 | Form 4 |
| May 19, 2026 | Deborah SteinDirector | Bought | 425 | $103.15 | $43,839 | Form 4 |
| May 5, 2026 | Christopher CarlsonChief Accounting Officer | Sold plan | 140 | $110.00 | $15,400 | Form 4 |
| Mar 18, 2026 | Deborah SteinDirector | Bought | 400 | $98.74 | $39,496 | Form 4 |
| Jan 21, 2026 | James Francis KesslerChief Executive Officer | Sold plan | 20,742 | $115.00 | $2.4 million | Form 4 |
| Nov 13, 2025 | Deborah SteinDirector | Bought | 1,000 | $101.26 | $101,260 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Pass | Pass |
| Current ratio rose | Pass | Fail | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | Pass | Fail | Pass |
| F-score | 5 of 8 | 4 of 8 | 6 of 8 |
| Accruals ratio | −4.5% | −4.3% | −4.6% |
Compare
Put RB Global side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| RB Global | FY25 | 7.2% | 15.5% | 15.7% | 7.6% | 1.7x | 6 | |
| Copart | FY26 | 0.4% | 35.4% | 27.2% | 19.6% | −1.0x | 4 | Compare |
| Science Applications Intl | FY26 | −2.9% | 7.2% | 8.0% | 12.8% | 4.2x | 7 | Compare |
| KBR | FY25 | 1.0% | 10.0% | 6.6% | 15.8% | 2.2x | 7 | Compare |
| CoreCivic | FY25 | 12.7% | — | 2.4% | 6.6% | 3.2x | 7 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 1,127 | 971 | 1,170 | 1,319 | 1,377 | 1,417 | 1,734 | 3,680 | 4,284 | 4,591 |
| Revenue growth | — | −13.8% | 20.5% | 12.7% | 4.5% | 2.9% | 22.4% | 112.2% | 16.4% | 7.2% |
| Gross profit | 189 | 532 | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 136 | 108 | 185 | 223 | 263 | 241 | 454 | 471 | 761 | 713 |
| Net income | 92 | 75 | 122 | 149 | 170 | 152 | 320 | 206 | 413 | 428 |
| Diluted EPS (US$) | 0.85 | 0.69 | 1.11 | 1.36 | 1.54 | 1.36 | 2.86 | 1.04 | 2.01 | 2.04 |
| Diluted shares (millions) | 108 | 108 | 109 | 110 | 110 | 111 | 112 | 168 | 185 | 187 |
| Cash flow | ||||||||||
| Cash from operations | 178 | 148 | 144 | 333 | 258 | 318 | 463 | 544 | 932 | 978 |
| Capital expenditure | 19 | 11 | 17 | 14 | 14 | 10 | 32 | 228 | 167 | 259 |
| Free cash flow | 159 | 137 | 127 | 319 | 244 | 308 | 431 | 316 | 765 | 719 |
| Dividends paid | 70 | 73 | 76 | 82 | 92 | 104 | 115 | 298 | 206 | 258 |
| Share buybacks | 37 | 0 | 0 | 42 | 53 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,779 | 9 | 193 |
| Stock-based compensation | 20 | 20 | 23 | 13 | 17 | 31 | 42 | 56 | 62 | 66 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 208 | 268 | 238 | 360 | 279 | 326 | 494 | 576 | 534 | 532 |
| Debt incl. finance leases | 620 | 820 | 731 | 674 | 692 | 1,766 | 635 | 3,115 | 2,704 | 2,573 |
| Total assets | 1,600 | 2,017 | 2,052 | 2,229 | 2,352 | 3,593 | 2,864 | 12,037 | 11,807 | 12,143 |
| Total liabilities | 904 | 1,264 | 1,216 | 1,322 | 1,339 | 2,522 | 1,574 | 6,528 | 6,091 | 6,075 |
| Shareholders' equity | 687 | 740 | 831 | 902 | 1,007 | 1,071 | 1,290 | 5,017 | 5,224 | 5,571 |
| Margins and ratios | ||||||||||
| Gross margin | 16.7% | 54.7% | — | — | — | — | — | — | — | — |
| Operating margin | 12.0% | 11.1% | 15.8% | 16.9% | 19.1% | 17.0% | 26.2% | 12.8% | 17.8% | 15.5% |
| Net margin | 8.2% | 7.7% | 10.4% | 11.3% | 12.3% | 10.7% | 18.4% | 5.6% | 9.6% | 9.3% |
| Free cash flow margin | 14.1% | 14.1% | 10.9% | 24.2% | 17.7% | 21.7% | 24.9% | 8.6% | 17.9% | 15.7% |
| Return on capital | 11.4% | 8.7% | 11.2% | 13.7% | 14.4% | 9.1% | 18.1% | 7.7% | 7.6% | 7.6% |
| Return on equity | 13.2% | 10.5% | 15.5% | 17.2% | 17.8% | 14.6% | 27.1% | 6.5% | 8.1% | 7.9% |
| Return on assets | 6.8% | 4.2% | 6.0% | 7.0% | 7.4% | 5.1% | 9.9% | 2.8% | 3.5% | 3.6% |
| Net debt to EBITDA | 2.3x | 3.5x | 2.0x | 1.1x | 1.2x | 4.4x | 0.3x | 3.1x | 1.8x | 1.7x |